Bellerophon Therapeutics
BLPH
$0.05130
Share price
-6.90%
Change (1 day)
-99.34%
Change (1 year)
Categories
Earnings for Bellerophon Therapeutics (BLPH)
Earnings in 2023 (TTM): -$11.04 M
According to Bellerophon Therapeutics 's latest financial reports the company's current earnings (TTM) are -$11.04 M. In 2022 the company made an earning of -$22.39 M a decrease over its 2021 earnings that were of -$20.17 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bellerophon Therapeutics from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$11.04 M | -50.7% |
| 2022 | -$22.39 M | 11.03% |
| 2021 | -$20.17 M | -24.22% |
| 2020 | -$26.61 M | 52.25% |
| 2019 | -$17.48 M | -37.33% |
| 2018 | -$27.88 M | 13.34% |
| 2017 | -$24.6 M | 3.54% |
| 2016 | -$23.76 M | -48.98% |
| 2015 | -$46.57 M | -22.15% |
| 2014 | -$59.82 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $6.66 B | -60,489.67% | 🇺🇸 USA |
 Baxter BAX | -$47 M | 325.92% | 🇺🇸 USA |
 Lantheus Holdings LNTH | $0.43 B | -4,005.41% | 🇺🇸 USA |
 Abeona Therapeutics
ABEO | -$54.19 M | 391.06% | 🇺🇸 USA |